NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020. uri icon

Overview

abstract

  • The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.

authors

publication date

  • March 1, 2020

Research

keywords

  • Antineoplastic Agents, Immunological
  • Neoplasms

Identity

Scopus Document Identifier

  • 85081374182

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2020.0012

PubMed ID

  • 32135517

Additional Document Info

volume

  • 18

issue

  • 3